INSM
Insmed Incorporated
October 29, 2026 · pre-market
- Rarity
- 3.79
- Peak move
- +19.29%
- Float cap
- $20.4B
Still running — rarity and peak move can only rise from here.
Insmed Incorporated is a global biopharmaceutical company that develops and commercializes therapies for patients with serious diseases. Its commercial products are ARIKAYCE for MAC lung disease and BRINSUPRI for non-cystic fibrosis bronchiectasis. Its pipeline spans respiratory, immunology and inflammation, and neuro and other rare diseases.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNot searched yet.A blank here does not mean there was no cause.